| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/27/2009 | US7482490 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482471 catalytic reaction of 4-(oxiranylmethoxy)carbazole with N-2-[2-(methoxy)phenoxy]ethyl]benzylamine in aprotic solvent; debenzylation of N-benzyl carvidilol to form carvidilol; less Pd catalyst needed; byproduct inhibition; high yield, industrial scale, racemic or enantiomeric forms |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/22/2009 | WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same |
| 01/22/2009 | WO2009009812A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/22/2009 | US20090023934 Process for preparing an intermediate to opioid receptor antagonists |
| 01/22/2009 | US20090023798 Thiohydroxamates as inhibitors of histone deacetylase |
| 01/22/2009 | US20090023797 Indol-Alanine Derivatives as Selective S1P4-Agonists |
| 01/22/2009 | US20090023796 Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023741 Aryl/hetarylamides as modulators of the ep2 receptor |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors |
| 01/22/2009 | US20090023721 Novel Substituted Tetracyclic Tetrahydrofuran, Pyrrolidine and Tetrahydrothiophene Derivatives and Their Use as a Medicament |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
| 01/22/2009 | US20090023710 Compound |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023085 Photosensitive Compositions, Curable Compositions, Novel Compounds, Photopolymerizable Compositions, Color Filters, and Planographic Printing Plate Precursors |
| 01/22/2009 | US20090021149 Emitting Materials and Organic Light Emitting Device Using the Same |
| 01/22/2009 | US20090021146 Organic compound, charge transport material and organic electroluminescent device |
| 01/22/2009 | DE102006014320B4 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase |
| 01/22/2009 | CA2693015A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016053A2 Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes |
| 01/21/2009 | EP2016052A1 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate |
| 01/21/2009 | EP2016051A2 Beta-crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same |
| 01/21/2009 | EP2016050A2 A process for the purification of ropinirole hydrochloride |
| 01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
| 01/21/2009 | EP1641894B1 Novel materials for electroluminescence |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101351445A Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN100453602C Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds |
| 01/21/2009 | CN100453552C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2338794C New oral formulation for 5-ht4 agonists or antagonists |
| 01/20/2009 | CA2331758C Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 01/20/2009 | CA2325526C Aryl phenyl substituted cyclic ketoenols |
| 01/15/2009 | WO2009008009A1 Novel crystalline form b of carvedilol dihydrogen phosphate |
| 01/15/2009 | WO2009007259A1 Process for the preparation of an indole derivative |
| 01/15/2009 | WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 01/15/2009 | US20090018338 Treatment of CRTH2-Mediated diseases and conditions |
| 01/15/2009 | US20090018311 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 01/15/2009 | US20090018170 5-lipoxygenase-activating protein (flap) inhibitors |
| 01/15/2009 | US20090018145 Compositions and their use as anti-tumor agents |
| 01/15/2009 | US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090017509 Method for the production of ramipril |
| 01/15/2009 | US20090017331 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 01/15/2009 | US20090017330 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 01/15/2009 | US20090017307 Process for the Preparation of Organic Materials |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | US20090015140 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device |
| 01/15/2009 | DE112007000484T5 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins |
| 01/14/2009 | EP2014649A1 Novel amorphous carvedilol dihydrogen phosphate |
| 01/14/2009 | EP2014648A1 Process for producing polycyclic proline derivative or acid adduct salt thereof |
| 01/14/2009 | EP2014647A1 Process for producing polycyclic lactam |
| 01/14/2009 | EP2014645A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/14/2009 | EP2014287A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013170A1 4-squarylpiperazine derivatives as antiviral agents |
| 01/14/2009 | EP2013169A1 Indole amide derivatives as ep4 receptor antagonists |
| 01/14/2009 | EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/14/2009 | EP1917242B1 Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
| 01/14/2009 | EP1478363B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/14/2009 | CN101346352A Asymmetric reduction method |
| 01/14/2009 | CN101346350A Method for production of heteroaromatic ring compound having n-rf group |
| 01/14/2009 | CN101346243A Optical recording medium and azacyanine dye |
| 01/14/2009 | CN101343539A Synthesis of novel organic luminescent material containing carbazolyl toluylene derivant structure and application thereof |
| 01/14/2009 | CN100451006C Carboxyl acylamide compound and its preparing method and use |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/13/2009 | US7476759 Matrix metalloproteinase inhibitors |
| 01/13/2009 | US7476746 PPAR active compounds |
| 01/13/2009 | US7476745 Stilbene derivatives, light-emitting element and light-emitting device |
| 01/13/2009 | US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | CA2369626C Use of cell membrane penetrating indigoid bisindole derivatives |
| 01/13/2009 | CA2322177C Process for the purification of (±)-2-azabicyclo[2.2.1]hept-5-en-3-one |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009003898A1 Organic light-emitting diodes containing carbene transition metal complex emitters and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides and disilyldibenzothiophene s,s-dioxides |
| 01/08/2009 | WO2009003307A1 Phthiobuzonum derivatives and preparation, pharmaceutical composition and use thereof |
| 01/08/2009 | WO2008128750A3 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof |
| 01/08/2009 | WO2008100867A3 Novel inhibitors hepatitis c virus replication |
| 01/08/2009 | US20090012311 Process for the preparation of indole derivatives |